Mei-Yin Polley

14PUBLICATIONS
152CO-AUTHORS
Radiation therapyMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Aug 08, 2025
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

|Aug 08, 2025
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.

Nicholas J Neill, Shankha Satpathy, Karsten Krug

|Jan 23, 2024
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils.

Mei-Yin C Polley, Daniel Schwartz, Theodore Karrison

|Jun 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.

Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley

Pageof 3

Frequent Collaborators

5 joint publications

Minesh P Mehta

4 joint publications

Andy B Lassman

3 joint publications

Charles M Perou

2 joint publications

Ann Partridge